End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1598 SEK | -3.03% | +3.77% | -28.98% |
05-07 | Cell Impact AB Signs Main Agreement with F.C.C | CI |
04-26 | Cell Impact AB Signs Agreement Valued At SEK 3.2 Million | CI |
Sales 2022 | 91.53M 8.38M 672M | Sales 2023 | 47.66M 4.37M 350M | Capitalization | 133M 12.19M 977M |
---|---|---|---|---|---|
Net income 2022 | -104M -9.53M -763M | Net income 2023 | -121M -11.08M -888M | EV / Sales 2022 | 7.76 x |
Net cash position 2022 | 120M 10.99M 881M | Net cash position 2023 | 57.14M 5.23M 420M | EV / Sales 2023 | 1.59 x |
P/E ratio 2022 |
-7.96
x | P/E ratio 2023 |
-0.2
x | Employees | 80 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 75.94% |
1 day | -3.03% | ||
1 week | +3.77% | ||
Current month | +3.77% | ||
1 month | -1.72% | ||
3 months | -4.31% | ||
6 months | -85.86% | ||
Current year | -28.98% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vallin
CEO | Chief Executive Officer | 47 | 31/12/20 |
Human Resources Officer | 52 | 31/12/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 31/12/21 | |
Mats Franzén
CHM | Chairman | 55 | 31/12/22 |
Date | Price | Change | Volume |
---|---|---|---|
07/05/24 | 0.1598 | -3.03% | 2,367,686 |
06/05/24 | 0.1648 | +0.49% | 6,026,718 |
03/05/24 | 0.164 | -1.80% | 2,185,828 |
02/05/24 | 0.167 | +8.44% | 8,201,287 |
30/04/24 | 0.154 | +10.32% | 2,681,748 |
End-of-day quote Nasdaq Stockholm, May 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-28.98% | 8.74M | |
+74.12% | 4.37B | |
+11.01% | 2.1B | |
+5.76% | 2.1B | |
-4.77% | 1.95B | |
-9.54% | 1.49B | |
+1.90% | 1.49B | |
+16.61% | 1.41B | |
-26.60% | 1.34B | |
-14.79% | 1.28B |
- Stock Market
- Equities
- CI Stock